-
Markets
-
Aktien
Sustainable finance2025 Euronext ESG Trends ReportWeiterlesenA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesWeiterlesenThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeWeiterlesenInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondWeiterlesenFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesWeiterlesenTrade mini bond futures on main European government bonds
-
Rohstoffe
- Übersicht
- Kurse überblick
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesWeiterlesenEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameWeiterlesenJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 14 Apr 2023 17:35 CEST |
ONXEO | Onxeo publiera ses résultats annuels le 21 avril 2023 | 20103010 Biotechnology | Other subject |
| 14 Apr 2023 17:35 CEST |
ONXEO | Onxeo Will Publish Its Full-year Results on April 21, 2023 | 20103010 Biotechnology | Other subject |
| 14 Mar 2023 18:00 CET |
ONXEO | Onxeo publiera ses résultats annuels le 14 avril 2023 | 20103010 Biotechnology | Other subject |
| 14 Mar 2023 18:00 CET |
ONXEO | Onxeo Will Publish Its Full-year Results on April 14, 2023 | 20103010 Biotechnology | Other subject |
| 06 Feb 2023 19:29 CET |
ONXEO | Onxeo : compte rendu de l’assemblée générale extraordinaire du 6 février 2023 | 20103010 Biotechnology | General meeting / Board Meeting |
| 06 Feb 2023 19:29 CET |
ONXEO | Onxeo: Report on the Extraordinary General Meeting of February 6, 2023 | 20103010 Biotechnology | General meeting / Board Meeting |
| 27 Jan 2023 18:00 CET |
ONXEO | Onxeo annonce son calendrier financier 2023 | 20103010 Biotechnology | Other subject |
| 27 Jan 2023 18:00 CET |
ONXEO | Onxeo Announces its Financial Agenda for 2023 | 20103010 Biotechnology | Other subject |
| 25 Jan 2023 18:00 CET |
ONXEO | ONXEO fait le point sur le programme de développement clinique de son candidat médicament first-in-class AsiDNATM | - | Other subject |
| 25 Jan 2023 18:00 CET |
ONXEO | ONXEO Provides Update on the Development Program For Its First-in-class Drug Candidate AsiDNATM | - | Other subject |
| 18 Jan 2023 18:27 CET |
ONXEO | Onxeo : Assemblée Générale Extraordinaire du 6 février 2023 : mise à disposition des documents préparatoires | 20103010 Biotechnology | General meeting / Board Meeting |
| 18 Jan 2023 18:27 CET |
ONXEO | Onxeo: Extraordinary General Meeting of February 6, 2023: Availability of Preparatory Documents | 20103010 Biotechnology | General meeting / Board Meeting |
| 04 Jan 2023 20:41 CET |
ONXEO | BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC KEPLER CHEUVREUX | 20103010 Biotechnology | Other subject |
| 04 Jan 2023 20:41 CET |
ONXEO | Half-year liquidity contract statement for ONXEO | 20103010 Biotechnology | Other subject |